Santos David A
Insider CIK 1820066 · RIGL EVP, Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RIGL RIGEL PHARMACEUTICALS INC | F Tax w/h | 2026-09-01 | 2026-09-03 | 874 | $47.50 | $41.5K | 61,622 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | F Tax w/h | 2026-09-01 | 2026-09-03 | 874 | $47.50 | $41.5K | 61,622 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2026-06-17 | 2026-06-22 | 7,394 | — | $0 | 7,394 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | F Tax w/h | 2026-06-01 | 2026-06-03 | 874 | $29.86 | $26.1K | 61,996 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2026-02-17 | 2026-02-19 | 19,430 | — | $0 | 62,870 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | F Tax w/h | 2026-02-10 | 2026-02-12 | 3,546 | $34.62 | $122.8K | 43,440 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | F Tax w/h | 2026-02-02 | 2026-02-04 | 5,718 | $36.01 | $205.9K | 46,986 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2025-09-15 | 2025-09-17 | 7,394 | — | $0 | 7,394 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2025-03-17 | 2025-03-19 | 6,875 | — | $0 | 6,875 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2025-03-17 | 2025-03-19 | 7,850 | — | $0 | 7,850 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2025-02-05 | 2025-02-06 | 1,796 | $21.93 | $39.4K | 51,704 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2025-02-04 | 2025-02-06 | 2,125 | $20.92 | $44.5K | 53,500 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2025-01-29 | 2025-01-31 | 14,788 | — | $0 | 14,788 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2025-01-29 | 2025-01-31 | 19,717 | — | $0 | 55,625 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2024-11-25 | 2024-11-26 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2024-02-28 | 2024-03-01 | 80,000 | — | $0 | 80,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2024-02-28 | 2024-03-01 | 78,500 | — | $0 | 78,500 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2024-02-05 | 2024-02-06 | 8,918 | $1.14 | $10.2K | 349,093 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2024-02-02 | 2024-02-06 | 5,601 | $1.13 | $6.3K | 358,011 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2024-01-23 | 2024-01-25 | 157,000 | — | $0 | 157,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2024-01-23 | 2024-01-25 | 209,000 | — | $0 | 363,612 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2023-02-02 | 2023-02-06 | 5,388 | $1.66 | $8.9K | 144,612 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2023-01-26 | 2023-01-30 | 160,000 | — | $0 | 160,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2023-01-26 | 2023-01-30 | 50,000 | — | $0 | 100,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2023-01-26 | 2023-01-30 | 80,000 | — | $0 | 150,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2022-12-28 | 2022-12-30 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2022-01-24 | 2022-01-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2022-01-24 | 2022-01-26 | 50,000 | — | $0 | 60,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2021-01-27 | 2021-01-29 | 137,500 | — | $0 | 137,500 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2020-08-19 | 2020-08-20 | 250,000 | — | $0 | 250,000 | SEC↗ |